Nanoly Bioscience, Inc, based in Denver, specializes in the development of polymers designed to enhance the stability of vaccines, allowing them to remain effective without the need for refrigeration.
The company's innovative approach aims to address the challenges of vaccine distribution in remote or resource-limited areas, potentially revolutionizing global healthcare delivery.
Generated from their website's infomation